BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15050683)

  • 1. Bax-ablation attenuates experimental autoimmune encephalomyelitis in mice.
    Lev N; Barhum Y; Melamed E; Offen D
    Neurosci Lett; 2004 Apr; 359(3):139-42. PubMed ID: 15050683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
    Herrero-Herranz E; Pardo LA; Gold R; Linker RA
    Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
    Moore CS; Hebb AL; Blanchard MM; Crocker CE; Liston P; Korneluk RG; Robertson GS
    J Neuroimmunol; 2008 Oct; 203(1):79-93. PubMed ID: 18687476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE).
    Offen D; Kaye JF; Bernard O; Merims D; Coire CI; Panet H; Melamed E; Ben-Nun A
    J Mol Neurosci; 2000 Dec; 15(3):167-76. PubMed ID: 11303781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses.
    Papadopoulos D; Rundle J; Patel R; Marshall I; Stretton J; Eaton R; Richardson JC; Gonzalez MI; Philpott KL; Reynolds R
    J Neurosci Res; 2010 Feb; 88(2):346-59. PubMed ID: 19658199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination.
    Mc Guire C; Volckaert T; Wolke U; Sze M; de Rycke R; Waisman A; Prinz M; Beyaert R; Pasparakis M; van Loo G
    J Immunol; 2010 Dec; 185(12):7646-53. PubMed ID: 21068410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
    Bannerman PG; Hahn A
    J Neurol Sci; 2007 Sep; 260(1-2):23-32. PubMed ID: 17493638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses.
    Linker RA; Rott E; Hofstetter HH; Hanke T; Toyka KV; Gold R
    Neurobiol Dis; 2005; 19(1-2):218-28. PubMed ID: 15837577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
    J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.
    Lyons JA; Ramsbottom MJ; Cross AH
    Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
    Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments.
    Huizinga R; Gerritsen W; Heijmans N; Amor S
    Neurobiol Dis; 2008 Dec; 32(3):461-70. PubMed ID: 18804534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell-mediated disruption of the neuronal microtubule network: correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis.
    Shriver LP; Dittel BN
    Am J Pathol; 2006 Sep; 169(3):999-1011. PubMed ID: 16936273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper/zinc chelation by clioquinol reduces spinal cord white matter damage and behavioral deficits in a murine MOG-induced multiple sclerosis model.
    Choi BY; Jang BG; Kim JH; Seo JN; Wu G; Sohn M; Chung TN; Suh SW
    Neurobiol Dis; 2013 Jun; 54():382-91. PubMed ID: 23360710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
    Papadopoulos D; Pham-Dinh D; Reynolds R
    Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.
    Chan J; Ban EJ; Chun KH; Wang S; McQualter J; Bernard C; Toh BH; Alderuccio F
    Autoimmunity; 2008 Aug; 41(5):405-13. PubMed ID: 18568646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.
    Linker RA; Lee DH; Demir S; Wiese S; Kruse N; Siglienti I; Gerhardt E; Neumann H; Sendtner M; Lühder F; Gold R
    Brain; 2010 Aug; 133(Pt 8):2248-63. PubMed ID: 20826430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.